Power Law company profile

Shield Therapeutics

Biotech & Life Sciences · Gateshead, United Kingdom · Founded 2008 · IPO 2016 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$143M

Market cap · Apr/2026

Revenue

$32M

Latest reported FY

Investors

2 investors on Shield Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

Series B+ 1 investor entered at this stage

Global footprint

Web traffic by country

800 monthly visits
across markets

🇺🇸 United States75%

🇮🇳 India25%

Top 2 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo